Ten novel device or indication approvals were added to Medtech Insight's Approvals Tracker last week, including US approval for Stryker's Surpass Streamline flow diverter for treating aortic aneurysms.
The approval, for use in patients with an unruptured large or giant saccular wide-neck or fusiform intracranial aneurysm, makesSurpass the second flow diverter approved in the US, after Medtronic's Pipeline...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?